Verastem, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Verastem, Inc. (VSTM) reported Net Income (Loss) Available to Common Stockholders, Basic of -$13.01 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2017-05-10
- Verastem, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2017-03-31 was -$13.01M.
- Verastem, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2016-12-31 was -$11.65M.
- Verastem, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2016-09-30 was -$7.92M.
- Verastem, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2016-06-30 was -$8.57M.
- Verastem, Inc. net income (loss) available to common stockholders, basic for fiscal 2016 was -$36.44M.
- Verastem, Inc. net income (loss) available to common stockholders, basic for fiscal 2015 was -$57.87M.
- Verastem, Inc. net income (loss) available to common stockholders, basic for fiscal 2014 was -$53.37M.
- Verastem, Inc. net income (loss) available to common stockholders, basic for fiscal 2013 was -$41.20M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 5 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 20 month | Net Income (Loss) Available to Common Stockholders, Basic 23 month | Net Income (Loss) Available to Common Stockholders, Basic 26 month | Net Income (Loss) Available to Common Stockholders, Basic 29 month | Net Income (Loss) Available to Common Stockholders, Basic 32 month | Net Income (Loss) Available to Common Stockholders, Basic 35 month | Net Income (Loss) Available to Common Stockholders, Basic 38 month | Net Income (Loss) Available to Common Stockholders, Basic 41 month | Net Income (Loss) Available to Common Stockholders, Basic 44 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | -$13.01M 10-Q · filed 2017-05-10 | -$24.66M derived: sum of 2 quarters · filed 2017-05-10 | -$32.58M derived: sum of 3 quarters · filed 2017-05-10 | -$41.15M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||||
| 2016-12-31 | -$11.65M 10-K · filed 2017-03-23 | -$19.58M derived: sum of 2 quarters · filed 2017-03-23 | -$28.15M derived: sum of 3 quarters · filed 2017-03-23 | -$36.44M 10-K · filed 2017-03-23 | ||||||||||
| 2016-09-30 | -$7.92M 10-K · filed 2017-03-23 | -$16.49M derived: sum of 2 quarters · filed 2017-03-23 | -$24.79M derived: sum of 3 quarters · filed 2017-05-10 | -$36.65M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||||
| 2016-06-30 | -$8.57M 10-K · filed 2017-03-23 | -$16.86M derived: sum of 2 quarters · filed 2017-05-10 | -$28.73M derived: sum of 3 quarters · filed 2017-05-10 | -$44.17M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||||
| 2016-03-31 | -$8.29M 10-Q · filed 2017-05-10 | -$20.16M derived: sum of 2 quarters · filed 2017-05-10 | -$35.60M derived: sum of 3 quarters · filed 2017-05-10 | -$50.98M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||||
| 2015-12-31 | -$11.86M 10-K · filed 2017-03-23 | -$27.31M derived: sum of 2 quarters · filed 2017-03-23 | -$42.69M derived: sum of 3 quarters · filed 2017-03-23 | -$57.87M 10-K · filed 2017-03-23 | ||||||||||
| 2015-09-30 | -$15.45M 10-K · filed 2017-03-23 | -$30.82M derived: sum of 2 quarters · filed 2017-03-23 | -$46.00M derived: sum of 3 quarters · filed 2017-03-23 | |||||||||||
| 2015-06-30 | -$15.38M 10-K · filed 2017-03-23 | -$30.56M derived: sum of 2 quarters · filed 2017-03-23 | ||||||||||||
| 2015-03-31 | -$15.18M 10-K · filed 2017-03-23 | |||||||||||||
| 2014-12-31 | -$53.37M 10-K · filed 2017-03-23 | |||||||||||||
| 2014-03-31 | -$13.06M 10-Q · filed 2014-05-08 | -$24.39M derived: sum of 2 quarters · filed 2015-03-10 | -$34.98M derived: sum of 3 quarters · filed 2015-03-10 | -$45.23M derived: sum of 4 quarters · filed 2015-03-10 | -$100.75M 10-Q · filed 2014-05-08 | |||||||||
| 2013-12-31 | -$11.32M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-10 | -$21.91M derived: sum of 2 quarters · filed 2015-03-10 | -$32.16M derived: sum of 3 quarters · filed 2015-03-10 | -$41.20M 10-K · filed 2015-03-10 | -$87.69M 10-K · filed 2014-03-06 | |||||||||
| 2013-09-30 | -$10.59M 10-Q · filed 2013-11-12 | -$20.84M derived: sum of 2 quarters · filed 2013-11-12 | -$29.88M 10-Q · filed 2013-11-12 | -$37.80M derived: sum of 4 quarters · filed 2015-03-10 | -$76.37M 10-Q · filed 2013-11-12 | |||||||||
| 2013-06-30 | -$10.25M 10-Q · filed 2013-08-13 | -$19.29M 10-Q · filed 2013-08-13 | -$27.21M derived: sum of 3 quarters · filed 2015-03-10 | -$37.58M derived: sum of 4 quarters · filed 2015-03-10 | -$65.78M 10-Q · filed 2013-08-13 | |||||||||
| 2013-03-31 | -$9.04M 10-Q · filed 2014-05-08 | -$16.96M derived: sum of 2 quarters · filed 2015-03-10 | -$27.32M derived: sum of 3 quarters · filed 2015-03-10 | -$34.15M derived: sum of 4 quarters · filed 2015-03-10 | -$55.53M 10-Q · filed 2013-05-09 | |||||||||
| 2012-12-31 | -$7.92M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-10 | -$18.29M derived: sum of 2 quarters · filed 2015-03-10 | -$25.11M derived: sum of 3 quarters · filed 2015-03-10 | -$31.99M 10-K · filed 2015-03-10 | -$46.49M 10-K · filed 2013-03-26 | |||||||||
| 2012-09-30 | -$10.37M 10-Q · filed 2013-11-12 | -$17.19M derived: sum of 2 quarters · filed 2013-11-12 | -$24.07M 10-Q · filed 2013-11-12 | -$30.09M derived: sum of 4 quarters · filed 2014-03-06 | -$38.57M 10-Q · filed 2012-11-13 | |||||||||
| 2012-06-30 | -$6.83M 10-Q · filed 2013-08-13 | -$13.70M 10-Q · filed 2013-08-13 | -$19.72M derived: sum of 3 quarters · filed 2014-03-06 | -$23.78M derived: sum of 4 quarters · filed 2014-03-06 | -$28.20M 10-Q · filed 2012-08-13 | |||||||||
| 2012-03-31 | -$6.88M 10-Q · filed 2013-05-09 | -$12.90M derived: sum of 2 quarters · filed 2014-03-06 | -$16.95M derived: sum of 3 quarters · filed 2014-03-06 | -$19.44M derived: sum of 4 quarters · filed 2014-03-06 | -$21.38M 10-Q · filed 2012-05-14 | |||||||||
| 2011-12-31 | -$6.02M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | -$10.08M derived: sum of 2 quarters · filed 2014-03-06 | -$12.56M derived: sum of 3 quarters · filed 2014-03-06 | -$13.71M 10-K · filed 2014-03-06 | ||||||||||
| 2011-09-30 | -$4.06M 10-Q · filed 2012-11-13 | -$6.55M derived: sum of 2 quarters · filed 2012-11-13 | -$7.70M 10-Q · filed 2012-11-13 | |||||||||||
| 2011-06-30 | -$2.49M 10-Q · filed 2012-08-13 | -$3.64M 10-Q · filed 2012-08-13 | ||||||||||||
| 2011-03-31 | -$1.15M 10-Q · filed 2012-05-14 | |||||||||||||
| 2010-12-31 | -$786.00K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |